小檗胺对高钾、去甲肾上腺素及咖啡因引起大鼠心肌细胞内钙动员的拮抗作用(英文)

目的:研究小檗胺(Ber)对氯化钾、NE及咖啡因引起大鼠培养心肌细胞[Ca~(2 )]_i动员的影响,方法:Fluo 3-AM负载后,共聚焦法测定心肌细胞[Ca~(2 )]_i荧光强度的变化。结果:Ber对心肌细胞静息[Ca~(2 )]_i水平无影响,但可剂量依赖性地抑制KCl60mmol·L~(-1)及NE 30 μmol·L~(-1)引起的内钙动员(P<0.01),此作用与维拉帕米相似.Egtazic acid3 mmol·L~(-1)并不能增强Ber对NE引起的[Ca~(2 )]_i升高的抑制作用,无外钙时,咖啡因80-160μmol·L~(-1)的[Ca~(2 )]_i动员不受Ber的影响(P>0.05),结论:Ber与维拉帕米相似,对大鼠心肌细胞靠电压依赖性和受体操纵性钙通道而升高的胞[Ca~(2 )]_i有拮抗作用,并不影响[Ca~(2 )]_i释放。     

甲基黄酮醇胺对分离的胎鼠脑细胞内游离钙浓度的影响(英文)

目的:观察甲基黄酮醇胺(MFA)对胎鼠脑细胞内游离钙浓度在静息以及激动剂存在时的作用。方法:用钙离子荧光染料Fura 2-AM负载后,测定分离的胎鼠脑细胞内游离钙浓度([Ca~(2 )]_i)及其变化。结果:在含钙1.3mmoL·L~(-1)的Hanks’液中,[Ca~(2 )]_i为197±20nmol·L~(-1)(n=44)。MFA0.15mmol·L~(-1)对静息脑细胞内钙浓度无明显影响。在细胞外钙1.3mmol·L~(-1)条件下,MFA(0.03—0.3 mmoL·L~(-1))浓度依赖性地抑制高钾去极化导致的[Ca~(2 )]_i升高,IC_(50)为0.14(95％可信限:0.05—0.42)mmoL·L~(-1)。在较高浓度时,MFA(0.15—0.3mmoL·L~(-1))也可抑制谷氨酸兴奋所引起的[Ca~(2 )]_i,IC_(50)为0.20(95％可信限:0.01—3.40)mmoL·L~(-1)。结论:MFA抑制高钾去极化引起的[Ca~(2 )]_i升高,在较高浓度时也拮抗谷氨酸兴奋所致的[Ca~(2 )]_i升高。     

甘草次酸钠对乳鼠心肌细胞的影响(英文)

目的:研究甘草次酸钠(SG)对乳鼠心肌细胞的作用。方法:体外培养乳鼠心肌细胞,用放射免疫法和荧光法分别测定cAMP和[Ca~(2 )]_i。结果:SG 0.4mmol·L~(-1)于5,10和15min使心肌细胞搏动频率由73±9min~(-1)分别降至62±5,59±7和56±6min~(-1)。SG0.1和0.2mmol·L~(-1)分别在15和10,15min呈现以上相似的结果。SG0.2和0.4mmol·L~(-1)与心肌细胞37℃共孵10,15min,cAMP浓度和[Ca~(2 )]_i均被降低。SG 0.2mmol·L~(-1)处理组的cAMP含量低于对照组(1.09±0.18,1.12±0.35pmol per vial,P<0.05);[Ca~(2 )]_i的变化也类似(30±4nmol·L~(-1),P<0.01,28±6nmol·L~(-1)P<0.05)。SG 0.1和0.2mmol·L~(-1)提高心肌细胞悬液氧分压变化率(87％±5％,75％±4％,P<0.01),但SG0.4mmol·L~(-1)降低氧分压变化率(31％±2％,P<0.01)。结论:SG可保护心肌或治疗缺血性心脏病。     

TMB-8抑制神经递质引起的单个脑细胞内游离钙的升高(英文)

目的:研究TMB-8对神经递质引起的单个脑细胞内游离钙升高的作用。方法:应用AR-CM-MIC阳离子测定系统测定游离大鼠单个脑细胞内钙离子浓度。结果:当细胞外液Ca~(2 )浓度为1.3mmol·L~(-1)时,TMB-8 30μmol·L~(-1)能降低谷氨酸,组织胺,5-羟色胺引起的脑[Ca~(2 )]_i浓度的升高。而当细胞外液无钙时,TMB-8能降低细胞内静息[Ca~(2 )]_i;TMB-8 10μmol·L~(-1)则几乎完全抑制了组织胺和5-羟色胺引起的脑[Ca~(2 )]_i升高作用。结论:TMB-8能降低谷氨酸,组织胺,5-羟色胺引起的脑[Ca~(2 )]_i升高。     

尼卡地平升高小鼠胸腺细胞胞浆钙浓度(英文)

研究尼卡地平(nicardipine,Nic)对小鼠胸腺细胞胞浆钙浓度([Ca~(2 )]_i)及增殖的影响.方法:用Fura-2掺入细胞的荧光测定法测定[ca~(2 )]_i;用[~3H]thymidine掺入法测定胸腺淋巴细胞的增殖.结果:无论在含Ca~(2 )或无Ca~(2 )介质中,Nic 1—30 μmol·L~(-1),以浓度依赖的方式升高静息胸腺细胞的[Ca~(2 )]_i.丝裂原Con A 5 mg·L~(-1)也从细胞内库释放Ca~(2 ),而Nic抑制Con A引起的[Ca~(2 )]_i升高.在上述升高[Ca~(2 )]_i的浓度中,Nic不刺激静息胸腺淋巴细胞增殖,但显著抑制Con A的增殖反应.结论:Nic升高[Ca~(2 )]_i,干扰了细胞Ca~(2 )稳态,因而抑制淋巴细胞对丝裂原的反应.     

钾通道开放剂降低血管平滑肌细胞内游离钙浓度(英文)

目的:研究PCO—Pin,Nic,Lem及RP对VMSC内[Ca~(2 )]_i的改变及其可能机制。方法:VSMC加入Fura-2 AM 2.5μmol·L~(-1)37℃下孵育50min,[Ca~(2 )]_i用荧光分光光度计检测。结果:4种PCO能较弱地抑制K~ 30 mmol·L~(-1)诱导的[Ca~(2 )]_i增加,但明显抑制ATP 0.1mmol·L~(-1)诱导的[Ca~(2 )]_i峰相及持续相增加,且呈剂量依赖性。格列苯脲完全阻断Pin,Lem及RP的作用,只部分抑制Nic的作用。无钙液中先给4种PCO,能显著抑制ATP诱导的[Ca~(2 )]_i峰相增加。结论:4种PCO均抑制ATP诱导的[Ca~(2 )]_i增加,此作用与减少细胞外钙内流及细胞内钙释放有关。     

MK-447对家兔凝血酶诱导的血小板聚集,ATP释放及细胞内游离钙动员的影响(英文)

目的:研究MK-447对家兔凝血酶诱导的血小板聚集释放反应及单细胞内钙水平的影响.方法:利用浊度法及测定PRP中ATP的含量评价聚集和释放反应,以荧光图像法分析细胞内钙浓度.结果:MK-447仅使兔多血小板血浆(PRP)透光度降低(DLT),即血小板变形,单血小板[Ca~(2 )]_i轻度增加(160 nmol·L~(-1)),并不被依他酸3 mmol·L~(-1)抑制.MK-447消除凝血酶诱导的DLT,聚集和ATP释放增强,呈剂量依赖性,且凝血酶介导的[Ca2 ]_i由369 ±45 nmol·L~(-1)增加到621±121 nmol·L~(-1).结论:MK-447的血小板变形与其[Ca~(2 )]_i释放有关.MK-447增强凝血酶的血小板聚集和ATP释放.MK-447的这一作用可能于[Ca2 ]_i的协同作用有关.     

小檗胺对培养的HeLa细胞内游离钙浓度的作用(英文)

目的:研究Ca~(2 )信号传导是否参与Hela细胞的信号传导过程以及小檗胺(Ber)对HeLa细胞内钙浓度([Ca~(2 )]_i)变化的影响。方法:Fluo 3-AM负载HeLa细胞,共聚焦法测定[Ca~(2 )]_i,结果以荧光强度(FI)表示。结果:(1)有外钙时,HeLa细胞静息FI为186±44,KCl、NE、Cal,及咖啡因均升高HeLa细胞的[Ca~(2 )]_i。(2)Ber处理后,静息FI无影响,但抑制KCl、NE和Cal引起的[Ca~(2 )]_i升高(P<0.01),FI变化的速率减慢,达峰值的时间延长。(3)无外钙时,咖啡因诱导的[Ca~(2 )]_i升高不被Ber抑制。(4)Ber的上述作用与Ver的作用相似。结论:HeLa细胞属于非兴奋性细胞,但部分生物学特征与兴奋性细胞相似,Ca~(2 )同样在其信息转导中发挥重要作用。     

粉防己碱对培养大鼠心肌细胞胞内游离钙的影响(英文)

目的:研究粉防己碱对心肌的作用。方法:采用Fura-2和AR-CM-MIC阳离子测定系统测定培养大鼠单个心肌细胞胞内游离钙。结果:外钙1.3mmol·L~(-1)时,细胞静息钙为90±12nmol·L~(-1)。粉防己碱不影响静息钙,但可明显抑制CaCl_2,KCl,哇巴因引起的胞内钙增高;对于去甲肾上腺素引起的胞内钙增高,粉防己碱只有在外钙存在时,方对其有抑制作用。结论;粉防己碱抑制钙离子的跨膜运动,但在心肌细胞,它并非是选择性的钙通道阻滞剂。     

大蒜新素对分离大鼠脑细胞内游离Ca~(2 )的影响

目的:观察大蒜新素对不同刺激剂所致分离大鼠脑细胞内游离钙的影响。方法:以Fura 2-AM为细胞内游离钙的荧光指示剂,用AR-CM-MIC阳离子测定系统,直接测定了分离新生大鼠脑细胞内游离钙([Ca~(2 )]_i)值,观察了大蒜新素的影响。结果:大蒜新素对脑细胞静息[Ca~(2 )]_i无明显影响,大蒜新素1-100μmol·L~(-1)能剂量依赖性地抑制高K~ 和谷氨酸引起的[Ca~(2 )]_i升高,其中IC_(50)分别为59.7和69.9μmol·L~(-1),高剂量大蒜新素100μmol·L~(-1)能抑制去甲肾上腺素引起的[Ca~(2 )]_i升高。结论:大蒜新素对高K~ 、去甲肾上腺素及谷氨酸引起的[Ca~(2 )]_i升高的抑制作用可能是其抗脑缺血作用机制之一。     

Efficacy of gut lavage,hemodialysis, and hemoperfusion in the therapy of paraquat or diquat intoxication

Clinical and in vitro investigations were carried out to test the efficacy of gut lavage, hemodialysis, and hemoperfusion in the treatment of poisoning with paraquat or diquat. In a patient suffering from diquat intoxication 130 times more diquat was removed by gut lavage 30 h after ingestion than was removed by complete aspiration of the gastric contents.Determination of in vitro clearances for paraquat and diquat by hemodialysis showed that, at serum concentrations of 1–2 ppm, such as are frequently encountered in poisoning in man, toxicologically relevant quantities of herbicide cannot be removed from the body. At a concentration of 20 ppm, on the other hand, hemodialysis proved to be effective, the clearance being 70 ml/min at a blood flow rate of 100 ml/min. The efficacy of hemoperfusion with coated activated charcoal was on the whole better. Especially at concentrations around 1–2 ppm, the clearance values for hemoperfusion were some 5–7 times higher than those for hemodialysis.In a patient suffering from paraquat poisoning, both hemodialysis as well as hemoperfusion were carried out. The in vitro results could be confirmed: At serum concentrations of paraquat less than 1 ppm no clearance could be obtained by hemodialysis while by hemoperfusion with activated charcoal quite high clearance values were measured and the serum level dropped down to zero.

---

Zusammenfassung Klinische Untersuchungen und Laboratoriumsversuche wurden durchgeführt, um die Wirksamkeit von Darmspülung, Hämodialyse und Hämoperfusion bei Paraquat- und Deiquat-Vergiftungen zu prüfen.Bei einem Patienten wurde 30 Std nach Deiquat-Aufnahme durch Darmspülung 130mal mehr Deiquat entfernt als durch vollständige Aspiration des Mageninhaltes. In vitro-Versuche ergaben, daß bei Blutserumkonzentrationen von 1–2 ppm, die bei Vergiftungen oft gemessen werden, durch Hämodialyse keine toxikologisch relevanten Paraquat- oder Deiquat-Mengen entfernt werden können. Dagegen erwies sich die Hämodialyse bei 20 ppm und einer Blutumlaufgeschwindigkeit von 100 ml/min mit einer Clearance von 70 ml/min als wirksam. Die Hämoperfusion mit beschicheter Aktivkohle war in diesen Versuchen aber eindeutig überlegen, denn insbesondere bei Konzentrationen um 1–2 ppm waren die Clearance-Werte 5–7mal höher als bei der Hämodialyse.Die in vitro-Ergebnisse wurden bei einem Patienten mit einer Paraquat-Vergiftung bestätigt: Bei Konzentrationen unter 1 ppm war die Hämodialyse wirkungslos, während durch Hämoperfusion relativ hohe Clearance-Werte erreicht wurden, so daß der Serumspiegel rasch unter die Nachweisgrenze abfiel.

     

In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism

This study describes a new approach for organophosphorous (OP) antidotal treatment by encapsulating an OP hydrolyzing enzyme, OPA anhydrolase (OPAA), within sterically stabilized liposomes. The recombinant OPAA enzyme was derived from Alteromonas strain JD6. It has broad substrate specificity to a wide range of OP compounds: DFP and the nerve agents, soman and sarin. Liposomes encapsulating OPAA (SL)* were made by mechanical dispersion method. Hydrolysis of DFP by (SL)* was measured by following an increase of fluoride ion concentration using a fluoride ion selective electrode. OPAA entrapped in the carrier liposomes rapidly hydrolyze DFP, with the rate of DFP hydrolysis directly proportional to the amount of (SL)* added to the solution. Liposomal carriers containing no enzyme did not hydrolyze DFP. The reaction was linear and the rate of hydrolysis was first order in the substrate. This enzyme carrier system serves as a biodegradable protective environment for the recombinant OP-metabolizing enzyme, OPAA, resulting in prolongation of enzymatic concentration in the body. These studies suggest that the protection of OP intoxication can be strikingly enhanced by adding OPAA encapsulated within (SL)* to pralidoxime and atropine.     

Aquatic Insects and Trace Metals: Bioavailability,Bioaccumulation, and Toxicity

Abstract

The uptake of metals from food and water sources by insects is thought to be additive. For a given metal, the proportions taken up from water and food will depend both on the bioavailable concentration of the metal associated with each source and the mechanism and rate by which the metal enters the insect. Attempts to correlate insect trace metal concentrations with the trophic level of insects should be made with a knowledge of the feeding relationships of the individual taxa concerned. Pathways for the uptake of essential metals, such as copper and zinc, exist at the cellular level, and other nonessential metals, such as cadmium, also appear to enter via these routes. Within cells, trace metals can be bound to proteins or stored in granules. The internal distribution of metals among body tissues is very heterogeneous, and distribution patterns tend to be both metal and taxon specific. Trace metals associated with insects can be both bound on the surface of their chitinous exoskeleton and incorporated into body tissues. The quantities of trace meals accumulated by an individual reflect the net balance between the rate of metal influx from both dissolved and particulate sources and the rate of metal efflux from the organism. The toxicity of metals has been demonstrated at all levels of biological organization: cell, tissue, individual, population, and community. Much of the literature pertaining to the toxic effects of metals on aquatic insects is based on laboratory observations and, as such, it is difficult to extrapolate the data to insects in nature. The few experimental studies in nature suggest that trace metal contaminants can affect both the distribution and the abundance of aquatic insects. Insects have a largely unexploited potential as biomonitors of metal contamination in nature. A better understanding of the physico-chemical and biological mechanisms mediating trace metal bioavailability and exchange will facilitate the development of general predictive models relating trace metal concentrations in insects to those in their environment. Such models will facilitate the use of insects as contaminant biomonitors.     

Alzheimer’s disease – current trends in basic and clinical research. Highlights from the 16th ECNP

Advances in the molecular biological knowledge of neuronal nicotinic acetylcholine receptors (nAChRs) have led to a growing interest by the pharmaceutical industry in the development of novel compounds that selectively modulate nAChR function. The ability of (-)-nicotine, an activator of nAChRs, to enhance attentional aspects of cognition in animals and humans, to exert neuroprotective and anxiolytic-like effects, and presumably to mediate the negative correlation between smoking and Alzheimer's (and Parkinson's) Disease, has focused interest on the potential therapeutic utility of modulators of nAChR function for treatment of some of the deficits associated with these progressive, neurodegenerative conditions. Numerous compounds are known which activate nAChRs and which might serve as lead compounds toward the development of such agents. The pharmacologic diversity of neuronal nAChR subtypes suggests the possibility of developing selective compounds which would have more favourable side-effect profiles than existing agents. This broader class of agents, collectively called cholinergic channel modulators (ChCMs), is anticipated to encompass compounds which would have more favourable side-effect profiles than existing agents, which generally exhibit low selectivity. This selectivity may be achieved by preferentially activating some subtypes of nAChRs (i.e., Cholinergic Channel Activators, ChCAs) or inhibiting the function of other subtypes (Cholinergic Channel Inhibitors, ChCIs). An overview of the biology of nAChRs and the rationale for the use of ChCMs for the treatment of dementia related to neurodegenerative diseases are presented, followed by a discussion of lead compounds and compounds under consideration for clinical evaluation.     

Steroidal sapogenin contents in some domestic plants

In order to find out the values of the steroid resources for the future use. the compositions and contents of steroidal sapogenins from 13 domestic plants have been investigated. As a result,Dioscorea nipponica, D. quinqueloba andSmilax china were found to have large amount of diosgenin. And pennogenin inTrillium kamtschaticum andParis verticillata, yuccagenin inAllium fistulosum, hecogenin inAgave americana and neochlorogenin inSolanum nigum were appeared to be major steroidal sapogenins.